Both in Pharmaceuticals
China Pharma Holdings vs TransCode Therapeutics
Over the past year CPHI returned −62.8% and RNAZ returned −84.5%; their daily moves had a correlation of 0.07.
CPHI −62.8% RNAZ −84.5%Growth of $1, one year, split-adjusted
| Metric | CPHI | RNAZ |
|---|---|---|
| Price | $0.6063 | $1.63 |
| Market cap | $26.1M | $27.6M |
| Today | −2.98% | 0.00% |
| 1 month | −7.7% | +3.8% |
| 6 months | +17.7% | −78.9% |
| Year to date | −49.9% | −76.1% |
| 1 year | — | — |
| Revenue growth (YoY) | −7.5% | — |
| Gross margin | 8.8% | — |
| Net margin | −153.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 6.7× | — |
| Net cash | -$3.3M | $7.7M |
| Dividend yield | — | — |
| Volatility (60d) | 90.0% | 75.5% |
| Short % of float | 10.1% | 8.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).